Showing results (971-980 of 1,132) with videos related to

Sort By:
Pageof 114
Annals of Neurology|August 26, 2010
Assessment of JC virus DNA in blood and urine from natalizumab-treated patientsRichard A Rudick, Paul W O'Connor, Chris H Polman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2003
Dynamic assembly of surface structures in living cellsJulia Gorelik, Andrew I Shevchuk, Gregory I Frolenkov, et al.
Data in Brief|July 5, 2022
Monoclonal antibodies binding data for SARS-CoV-2 proteinsNawneet Mishra, Joan Teyra, RuthMabel Boytz, et al.
International Journal of Molecular Sciences|July 9, 2022
A Quantitative Assay for Ca<sup>2+</sup> Uptake through Normal and Pathological HemichannelsChiara Nardin, Abraham Tettey-Matey, Viola Donati, et al.
BMJ (Clinical Research Ed.)|March 10, 2017
Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trialJohn Furler, David O'Neal, Jane Speight, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|May 27, 2025
Optimizing Musculoskeletal Imaging Referrals: Making Wise Choices a Knee-Jerk ReactionNatalia Gorelik, Courtney R Green, Candyce Hamel, et al.
Nature Communications|January 21, 2016
Nanoscale visualization of functional adhesion/excitability nodes at the intercalated discAlejandra Leo-Macias, Esperanza Agullo-Pascual, Jose L Sanchez-Alonso, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2025
CRISPR screens and quantitative proteomics reveal remodeling of the aryl hydrocarbon receptor-driven proteome through PARP7 activityAndrii Gorelik, Joao A Paulo, Christina B Schroeter, et al.
NAR Genomics and Bioinformatics|October 20, 2023
Elevated A-to-I RNA editing in COVID-19 infected individualsRona Merdler-Rabinowicz, David Gorelik, Jiwoon Park, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 10, 2015
Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinomaKonstantin Kazankov, Anthony Rode, Kira Simonsen, et al.
Pageof 114